行尸走肉第三季
Employer-sponsored health coverage costs jumped this year. More hikes may be coming_我的网站

A | The cost of health coverage through work jumped this year, in part because of inflation, according to a survey of U.S. employers.Premiums for both family and single plans climbed 7% after barely rising in 2022, according to a report Wednesday by KFF, a nonprofit that researches health care issues.Later this fall, companies begin their annual coverage enrollment window for 2024, and health care experts say another price hike could be coming.“It’s hard to imagine that there won’t be another year of health care cost increases, at least at the level we’re seeing right now,” said Paul Fronstin, director of health benefits research for the Employee Benefit Research Institute.Employer-sponsored health insurance is the most common form of coverage in the United States. KFF says almost 153 million Americans have it. Companies generally pay most of the premium — 70% or more in many cases.That can soften the impact of price hikes on employees. Coverage costs also are taken out of paychecks before taxes, which helps mitigate the financial pinch workers may feel, noted Fronstin, who was not involved in the KFF study.KFF noted that premiums climbed roughly with wages and inflation. The wider economy has felt those two pressures for more than a year, and now they are starting to affect health care costs, said Gary Claxton, a senior vice president with KFF. He noted that there can be a delay because health care contracts can keep costs stable after prices start rising in other parts of the economy.Fronstin said health care provider consolidation also can drive up care costs, which ultimately affects premiums. He also thinks the U.S. health care system — with its limited capacity to treat people — is still catching up on providing care that was delayed during the COVID-19 pandemic.“There’s only so much room for catch up,” he said. “I don’t believe colonoscopy centers are running 24/7 to catch up.”___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.。 华泰证券研报称,上周海外债市共振调整、超长端领跌,但中债收益率不升反降,内外债市定价明显背离。海外长端上行并非单一国别事件,而是AI融资挤出国债需求、主权财政扩张和债务担忧、央行与机构需求收缩、通胀尾部风险升温的共同结果。华泰证券认为,美国财政部扩大回购杯水车薪,AI投资增速下滑、高利率反噬投资可能推动利率下行。国内利率定价仍由内需偏弱、资金面偏松和资产荒主导,海外利率更多约束利率下行空间。

B | 策略上,10年国债1.7%之下不建议追涨,但短期方向仍偏有利,维持存单与超长债组合,二永债等提防“固收+”赎回扰动,继续关注摊余成本债基重启带来的结构机会。
Current article:http://gqt.caonaishengpengchuali.shop/news/20260826_8401.html
Published on:15:45:15